Work Here?
Overview
Medrio provides cloud-based software for clinical trials, serving pharmaceutical, biotech, and CRO clients. Its platform streamlines activities from protocol design to submission of casebooks and includes Randomization and Trial Supply Management (RTSM) to efficiently randomize participants and control trial supplies. The RTSM capabilities cover configuring allocation rules, automating shipment approvals, and issuing issue alerts to improve supply-chain efficiency. The software is offered on a Software-as-a-Service (SaaS) basis, with subscription fees that scale by features and usage. Medrio differentiates itself through a user-friendly interface, a focus on enabling researchers to concentrate on science rather than technology, and a culture emphasizing inclusion, diversity, and a joyful work environment. The goal is to help life-sciences teams run clinical trials more smoothly, with reduced risk and steady, predictable software revenue to support growth.
About Medrio
Industries
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
Late Stage VC
Total Funding
$32M
Headquarters
New York City, New York
Founded
2005
Get referred to Medrio
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 13, 2026 roadmap showed 90% faster data refreshes in backend reporting.
- Trialt partnered with Medrio on February 10, 2026, expanding CRO distribution.
- CTMS already has live customers, and eTMF entered development with customer feedback guiding workflows.
What critics are saying
- G2 reviewers still flag functionality limits and cumbersome configuration for complex studies.
- The 2023 Frederickson breach-of-contract suit reached dismissal, but employee disputes still signal execution risk.
- Modernizing architecture while shipping AI features risks validation failures and delayed customer adoption through 2026.
What makes Medrio unique
- Medrio ranked #1 in G2’s Summer 2026 EDC report, tied for highest score.
- Its no-code RTSM targets complex trials, with March 26, 2025 deployments in weeks.
- Medrio is modernizing a full suite, adding CTMS, eTMF, and MCP connectors in 2026.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$32M
Above
Industry Average
Funded Over
2 Rounds
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Gym Membership
Flexible Work Hours
Unlimited Paid Time Off
Growth & Insights and Company News
6 month growth
↓ -2%1 year growth
↓ -3%2 year growth
↓ -2%Medrio, a global leader in clinical trial technology, announced enhancements to its randomization and trial supply management (RTSM) solution.
SAN FRANCISCO, March 26, 2025 /PRNewswire/ -- Medrio, a global leader in clinical trial technology, today announced enhancements to its randomization and trial supply management (RTSM) solution. This latest release delivers faster implementation, greater flexibility, and enhanced self-service capabilities."Our customers need RTSM to be as agile as the trials they run," said Nicole Latimer, Chief Executive Officer at Medrio. "By expanding our configurability capabilities, we're allowing teams to build, test, and deploy Medrio RTSM in a fraction of the time of traditional systems without relying on extensive vendor support."The latest IRT Benchmarking & Market Dynamics (5th Ed.) report cites that 77% of clinical trials now require moderate to high-complexity RTSM builds. This finding highlights the need for flexible and configurable RTSM systems. Designed in collaboration with customers, Medrio RTSM eliminates the barriers and complexity of traditional vendor-dependent setups. With no-code configurability, sponsors and CROs can build and deploy in weeks, not months."The Medrio RTSM build team has been great to work with, showing knowledge, professionalism, flexibility, and the ability to meet study timelines," said Kenneth Homer, Director of Biostatistics and Programming at Homer Biometrics, LLC
London-based Phastar has previously partnered with Medrio, a decentralized clinical trial technology company, on a tool for data visualization.
CHICAGO--(BUSINESS WIRE)--ComPsych® Corporation, the world’s largest provider of mental health services and GuidanceResources® for life, today announced the honorees of the 2023 Health at Work Awards. Now in its 19th year, the ComPsych Health at Work Awards recognize organizations across a variety of sizes, industries and locations who have prioritized the health and well-being of their employees by providing innovative, multi-platform programs. “We’re thrilled to honor these stellar organizations for the investment they’ve made in building cultures that value employee mental health and wellness,” said Dr. Richard A. Chaifetz, Founder, Chairman and CEO of ComPsych. “In recent years we’ve seen a rise in anxiety as well as people needing to take leaves of absence due to mental health challenges across the workforce
AICPA SOC badge “Assuring the safety and security of our customers’ data, as they navigate FDA or EMA approval, is our highest priority, so we are thrilled when industry leading assessments - whether it be SOC 2, ISO 27001, or ISO 9001:2015 - attest to our daily practices and rigor.” said Fred Martin, COO. Medrio, a global leader in eClinical software and services used in decentralized, hybrid, and traditional clinical trials, has successfully completed a System and Organization Controls (SOC) 2 Type 2 examination. The independent third-party report attests to the controls at Medrio regarding the security, availability, and confidentiality of its eClinical technology and solutions
Medrio is Hiring for 2 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Medrio
Industries
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
Late Stage VC
Total Funding
$32M
Headquarters
New York City, New York
Founded
2005
Medrio is Hiring for 2 Jobs on Simplify!
Find jobs on Simplify and start your career today